Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ecstasy - drug

Known as: 5-Methoxy-3,4-methylenedioxyamphetamine, 3,4 methylenedioxymethamphetamine, 3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine 
A ring-substituted amphetamine derivative, structurally related to the hallucinogen mescaline, with entactogenic, neurotoxic, and motor-stimulatory… Expand
National Institutes of Health

Related topics

Related topics

18 relations
3,4-MethylenedioxyamphetamineClub DrugsIn BloodMethamphetamine
Expand

Broader (5)

Adrenergic Uptake InhibitorsAmphetamineDesigner DrugsHallucinogens
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
p53 ubiquitination: Mdm2 and beyond.
Although early studies have suggested that the oncoprotein Mdm2 is the primary E3 ubiquitin ligase for the p53 tumor suppressor… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Electrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds.
In this article, ultrafine gelatin (Gt) fibers were successfully produced with the use of the electrical spinning or… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table II
Is this relevant?
Review
2003
Review
2003
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
The amphetamine derivative (±)-3,4-methylenedioxymethamphetamine (MDMA, ecstasy) is a popular recreational drug among young… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Non-destructive terahertz imaging of illicit drugs using spectral fingerprints.
The absence of non-destructive inspection techniques for illicit drugs hidden in mail envelopes has resulted in such drugs being… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2001
Review
2001
Incentive-sensitization and addiction.
The question of addiction concerns the process by which drug-taking behavior, in certain individuals, evolves into compulsive… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin
A large body of evidence supports the hypothesis that mesolimbic dopamine (DA) mediates, in animal models, the reinforcing… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.
The sodium-dependent, high affinity serotonin [5-hydroxytryptamine (5-HT)] transporter (5-HTT) provides the primary mechanism for… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance
Abstract Three groups of young people (aged 19–30 years) were compared: 15 regular ecstasy users who had taken MDMA (3,4… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")
The risk of adverse reactions to 3,4-methylenedioxymethamphetamine (MDMA), more commonly known as "ecstasy", is now widely known… Expand
Is this relevant?
Highly Cited
1990
Highly Cited
1990
Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A
THE first inductive interaction in amphibian development is mesoderm induction, when a signal from the vegetal hemisphere of the… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE